Influence of cytochrome P450 genotype on the plasma disposition of prochlorperazine metabolites and their relationships with clinical responses in cancer patients

MLA

Masaki Tashiro, et al. “Influence of Cytochrome P450 Genotype on the Plasma Disposition of Prochlorperazine Metabolites and Their Relationships with Clinical Responses in Cancer Patients.” Annals of Clinical Biochemistry, vol. 55, no. 3, Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d53eed9eb22386ca5d97abd11523cdc&authtype=sso&custid=ns315887.

APA

Masaki Tashiro, Junichi Kawakami, Yoshiyuki Kagawa, & Takafumi Naito. (2017). Influence of cytochrome P450 genotype on the plasma disposition of prochlorperazine metabolites and their relationships with clinical responses in cancer patients. Annals of Clinical Biochemistry, 55(3).

Chicago

Masaki Tashiro, Junichi Kawakami, Yoshiyuki Kagawa, and Takafumi Naito. 2017. “Influence of Cytochrome P450 Genotype on the Plasma Disposition of Prochlorperazine Metabolites and Their Relationships with Clinical Responses in Cancer Patients.” Annals of Clinical Biochemistry 55 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d53eed9eb22386ca5d97abd11523cdc&authtype=sso&custid=ns315887.